Circulating promastocytes and atypical mast cells in systemic mastocytosis associated with acute myelogenous leukaemia transformation

Myelogenous Leukaemia ◽

Acute myelogenous leukaemia in older patients at St Bartholomew's Hospital: outcome with mitoxantrone and cytarabine

The Hematology Journal ◽

10.1038/sj.thj.6200188 ◽

2002 ◽

Vol 3 (5) ◽

pp. 237-243 ◽

Cited By ~ 2

Author(s):

Christopher D Dalley ◽

Deborah L Lillington ◽

Michael Bradburn ◽

Maxine Carter ◽

John A Amess ◽

...

Keyword(s):

Older Patients ◽

Myelogenous Leukaemia ◽

Hospital Outcome ◽

Acute myelogenous leukaemia presenting as a conjunctival lesion and red eye

Acta Ophthalmologica Scandinavica ◽

10.1034/j.1600-0420.2002.800623_1.x ◽

2002 ◽

Vol 80 (6) ◽

pp. 671-672 ◽

Cited By ~ 5

Author(s):

Raymond S. Douglas ◽

Scott M. Goldstein ◽

Charles Nichols

Keyword(s):

Myelogenous Leukaemia ◽

Red Eye ◽

Acute Myelogenous ◽

Conjunctival Lesion

FDA approves first targeted drug for acute myelogenous leukaemia

Nature Reviews Drug Discovery ◽

10.1038/nrd.2017.110 ◽

2017 ◽

Vol 16 (6) ◽

pp. 375-375

Author(s):

Asher Mullard

Keyword(s):

Myelogenous Leukaemia ◽

Acute Myelogenous ◽

Targeted Drug

LONG-TERM REMISSION IN ACUTE MYELOGENOUS LEUKAEMIA

The Lancet ◽

10.1016/s0140-6736(84)90975-9 ◽

1984 ◽

Vol 323 (8376) ◽

pp. 571 ◽

Cited By ~ 7

Author(s):

T. Büchner ◽

D. Urbanitz ◽

B. Emmerich ◽

J. Fischer ◽

A. Heinecke ◽

...

Keyword(s):

Myelogenous Leukaemia ◽

Inducibility of lymphokine activated killer (LAK) cells in patients with acute myelogenous leukaemia in complete remission and its clinical relevance

British Journal of Haematology ◽

10.1111/j.1365-2141.1991.tb08579.x ◽

1991 ◽

Vol 77 (3) ◽

pp. 328-334 ◽

Cited By ~ 46

Author(s):

Eric Archimbaud ◽

Mireille Bailly ◽

Jean-Françlois Doré

Keyword(s):

Complete Remission ◽

Clinical Relevance ◽

Myelogenous Leukaemia ◽

Lak Cells ◽

Acute myelogenous leukaemia in a mare

Australian Veterinary Journal ◽

10.1111/j.1751-0813.1997.tb15702.x ◽

1997 ◽

Vol 75 (5) ◽

pp. 329-331 ◽

Cited By ~ 20

Author(s):

NC RINGGER ◽

L. EDENS ◽

P. BAIN ◽

RE RASKIN ◽

R. LAROCK

Keyword(s):

Myelogenous Leukaemia ◽

A randomized study of intermediate versus conventional-dose cytarabine as intensive induction for acute myelogenous leukaemia

British Journal of Haematology ◽

10.1111/j.1365-2141.1992.tb08203.x ◽

1992 ◽

Vol 81 (2) ◽

pp. 170-177 ◽

Cited By ~ 36

Author(s):

Gary Schiller ◽

James Gajewski ◽

Stephen Nimer ◽

Mary Territo ◽

Winston Ho ◽

...

Keyword(s):

Randomized Study ◽

Myelogenous Leukaemia ◽

Conventional Dose ◽

Older age is an independent risk factor in acute myelogenous leukaemia

Oncology Times UK ◽

10.1097/01434893-200902000-00010 ◽

2009 ◽

Vol 6 (2) ◽

pp. 10

Author(s):

Robert H Carlson

Keyword(s):

Risk Factor ◽

Independent Risk Factor ◽

Myelogenous Leukaemia ◽

Older Age ◽

Allogeneic bone marrow transplantation versus intensification chemotherapy for acute myelogenous leukaemia in first remission: a prospective controlled trial

British Journal of Haematology ◽

10.1111/j.1365-2141.1988.tb06193.x ◽

1988 ◽

Vol 68 (2) ◽

pp. 219-226 ◽

Cited By ~ 27

Author(s):

E. Conde ◽

A. Iriondo ◽

C. Rayon ◽

C. Richard ◽

E. Fanjul ◽

...

Keyword(s):

Bone Marrow ◽

Bone Marrow Transplantation ◽

Marrow Transplantation ◽

Controlled Trial ◽

Allogeneic Bone Marrow Transplantation ◽

Myelogenous Leukaemia ◽

Allogeneic Bone ◽

Acute Myelogenous ◽

First Remission

Immunotherapy alone vs no maintenance treatment in acute myelogenous leukaemia

British Journal of Cancer ◽

10.1038/bjc.1980.60 ◽

1980 ◽

Vol 41 (3) ◽

pp. 372-377 ◽

Cited By ~ 14

Author(s):

S R Zuhrie ◽

R Harris ◽

C B Freeman ◽

J E MacIver ◽

C G Geary ◽

...

Keyword(s):

Maintenance Treatment ◽

Myelogenous Leukaemia ◽